Andreeva IV et al. |
[Diagnostic and treatment patterns in management of male patients with nongonococcal urethritis: results of Russian multicentral cross-sectional study]. |
2012 |
Antibiot. Khimioter. |
pmid:23156042
|
Tets VV et al. |
[Characteristics of azithromycin action on bacterial biofilms of pneumonia pathogens]. |
2007 |
Antibiot. Khimioter. |
pmid:18476468
|
Chulig I |
[Pharmacokinetic profile of azithromycin. Role in the treatment of genital Chlamydia infections]. |
1996 |
Antibiot. Khimioter. |
pmid:8929112
|
Kuznetsova SM |
["Sumamed in the treatment of urogenital infections"]. |
1996 |
Antibiot. Khimioter. |
pmid:8929115
|
Skripkin IuK et al. |
[The problem of diagnosis and treatment of urogenital chlamydiosis in Russia]. |
1996 |
Antibiot. Khimioter. |
pmid:8929120
|
Saint-Criq V et al. |
Restoration of chloride efflux by azithromycin in airway epithelial cells of cystic fibrosis patients. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21220528
|
Sato T et al. |
In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21220530
|
Waag DM |
Efficacy of postexposure therapy against glanders in mice. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25645854
|
Peric M et al. |
Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12604536
|
Seral C et al. |
Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 murine macrophages. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12604540
|
Roblin PM et al. |
In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12604555
|
Rodvold KA et al. |
Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9174209
|
Solomon AW et al. |
Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16251338
|
Kirkcaldy RD et al. |
Analysis of Neisseria gonorrhoeae azithromycin susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25451056
|
Nahata MC et al. |
Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383944
|
Vaara M |
Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383945
|
Brown ST et al. |
Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8384809
|
Goldman RC et al. |
Role of protonated and neutral forms of macrolides in binding to ribosomes from gram-positive and gram-negative bacteria. |
1990 |
Antimicrob. Agents Chemother. |
pmid:2159256
|
Ohrt C et al. |
Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12121927
|
Gladue RP and Snider ME |
Intracellular accumulation of azithromycin by cultured human fibroblasts. |
1990 |
Antimicrob. Agents Chemother. |
pmid:2168141
|
Riska PF et al. |
Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15328134
|
Watt G et al. |
Azithromycin activities against Orientia tsutsugamushi strains isolated in cases of scrub typhus in Northern Thailand. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543774
|
Kutlin A et al. |
In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10471577
|
Bui KQ et al. |
Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10471584
|
Sugie M et al. |
Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin. |
2004 |
Antimicrob. Agents Chemother. |
pmid:14982769
|
den Hollander JG et al. |
Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527789
|
Bulman ZP et al. |
Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28096154
|
Pandori MW et al. |
Detection of azithromycin resistance in Treponema pallidum by real-time PCR. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17620374
|
Hoffmann N et al. |
Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17620382
|
Capobianco JO and Goldman RC |
Erythromycin and azithromycin transport into Haemophilus influenzae ATCC 19418 under conditions of depressed proton motive force (delta mu H). |
1990 |
Antimicrob. Agents Chemother. |
pmid:2178338
|
Geisler WM et al. |
Randomized, double-blind, multicenter safety and efficacy study of rifalazil compared with azithromycin for treatment of uncomplicated genital Chlamydia trachomatis infection in women. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24798277
|
Hoppe JE and Bryskier A |
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). |
1998 |
Antimicrob. Agents Chemother. |
pmid:9559823
|
Mallegol J et al. |
Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24277019
|
Bermudez LE et al. |
Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11120969
|
Fuentes F et al. |
Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527796
|
Kashuba AD and Amsden GW |
Bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527816
|
Heifets L et al. |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8031351
|
Wolinsky E |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031406
|
Taylor WR et al. |
Tolerability of azithromycin as malaria prophylaxis in adults in northeast papua, indonesia. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12821468
|
Nakajima T et al. |
Microbiological and Clinical Effects of Sitafloxacin and Azithromycin in Periodontitis Patients Receiving Supportive Periodontal Therapy. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26729495
|
Ravdin JI and Skilogiannis J |
In vitro susceptibilities of Entamoeba histolytica to azithromycin, CP-63,956, erythromycin, and metronidazole. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2548442
|
Kawai Y et al. |
Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23459497
|
Ressner RA et al. |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18411316
|
Carvalho-Assef AP et al. |
Detection of NDM-1-, CTX-M-15-, and qnrB4-producing Enterobacter hormaechei isolates in Brazil. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24449772
|
Goldstein EJ et al. |
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593139
|
Pankuch GA et al. |
In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniae. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9797225
|
Odenholt I et al. |
Studies of the killing kinetics of benzylpenicillin, cefuroxime, azithromycin, and sparfloxacin on bacteria in the postantibiotic phase. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9371360
|
Kosowska-Shick K et al. |
Activity of DX-619 compared to other agents against viridans group streptococci, Streptococcus bovis, and Cardiobacterium hominis. |
2006 |
Antimicrob. Agents Chemother. |
pmid:17043120
|
Phillips-Campbell R et al. |
Induction of the Chlamydia muridarum stress/persistence response increases azithromycin treatment failure in a murine model of infection. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24342653
|
Jang MO et al. |
Outcome of intravenous azithromycin therapy in patients with complicated scrub typhus compared with that of doxycycline therapy using propensity-matched analysis. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24366734
|